Cancer stem cell vaccine inhibits metastases of primary tumors and induces humoral immune responses against cancer stem cells
The inability to target cancer stem cells (CSC) may be a significant factor contributing to treatment failure. We have developed a strategy to target the CSC populations in melanoma and squamous cell carcinoma using CSC lysate-pulsed dendritic cells (DCs). The CSC-DC vaccine was administered in the...
Main Authors: | Lu, Lin, Tao, Huimin, Chang, Alfred E, Hu, Yangyang, Shu, Guoshun, Chen, Quanning, Egenti, Martin, Owen, John, Moyer, Jeffrey S, Prince, Mark EP, Huang, Shiang, Wicha, Max S, Xia, Jian-Chuan, Li, Qiao |
---|---|
Format: | Online |
Language: | English |
Published: |
Taylor & Francis
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4404925/ |
Similar Items
-
Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
by: Li, Qiao, et al.
Published: (2014) -
Promise of cancer stem cell vaccine
by: Zhou, Li, et al.
Published: (2015) -
Targeting cancer stem cells via dendritic-cell vaccination
by: Teitz-Tennenbaum, Seagal, et al.
Published: (2012) -
Metabolic plasticity of cancer stem cells
by: Luo, Ming, et al.
Published: (2015) -
Chemokines and cellular plasticity of ovarian cancer stem cells
by: Zou, Weiping, et al.
Published: (2015)